跳至主要内容
临床试验/NCT00374257
NCT00374257终止2 期

Narrow-Band UVB Phototherapy for Treatment of Oral Chronic Graft-versus-Host Disease

Brigham and Women's Hospital4 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2006年8月1日最近更新:

试验速览

阶段
2 期
状态
终止
入组人数
11
试验地点
4
主要终点
To clinically evaluate the treatment efficacy of NB-UVB phototherapy in the management of oral cGVHD.

研究概览

简要总结

The purpose of this trial is to find out how effective Narrow Band-Ultraviolet Light B (NB-UVB) phototherapy is in treating oral cGVHD. NB-UVB Phototherapy involves exposing the inside of the mouth to light of a particular spectrum (a specific wavelength of light, 311nm) of the ultraviolet band, called NB-UVB. It is known that narrow band ultraviolet light therapy can improve symptoms in patients with skin chronic GVHD.

详细描述

  • At the first visit the following information will be collected about the participant: original diagnosis, the date and type of transplant, transplant conditioning regimen, cGVHD prophylaxis regimen, the time when oral cGVHD was first noticed, specific treatments for oral cGVHD, and any current medications.
  • At each visit, and before the participant begins phototherapy treatment, they will answer a series of questions asking about how their mouth feels and what they are able to eat. A clinical examination of the mouth will be performed and recorded and photographs will be taken of the inside of the mouth.
  • Participants will then receive phototherapy treatment. This will take approximately three minutes and will involve opening the mouth and closing the eyes. Following phototherapy, the participant will be asked several questions on how they tolerated the treatment. Phototherapy treatments will be done two or three times per week for a total of 24 treatments. After each treatment, if the participant has not experienced any discomfort, the phototherapy dose will be increased following a specific protocol.
  • After 24 treatments the participant will have the option to continue phototherapy treatments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
4 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with oral chronic graft-versus-host disease
  • 4 years of age or older
  • Stable cGVHD medication regimen for the four weeks prior to study enrollment

排除标准

  • New immunomodulatory medications or increasing dosage of current immunomodulatory medications during the four weeks prior to study enrollment
  • Concurrent extracorporeal photopheresis.

结局指标

主要结局

To clinically evaluate the treatment efficacy of NB-UVB phototherapy in the management of oral cGVHD.

时间窗: 4 years

次要结局

  • To evaluate the convenience, ease of use, tolerability and practicality of NB-UVB phototherapy in this patient population(4 years)
  • to determine the effective maintenance doses/regimens in participants with good response for long-term management.(4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nathaniel Simon Treister

Principal Investigator

Brigham and Women's Hospital

研究点 (4)

Loading locations...

相似试验

UVB Phototherapy Treatment of Oral Chronic GVHD | 临床试验